Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy.

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy.

Item
http://www.wikidata.org/entity/Q45745942
Management of a patient with HIV infection-induced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura.Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era.Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.In Vivo validation of a bioinformatics based tool to identify reduced replication capacity in HIV-1.Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapyPreferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 study.Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition.A randomized trial of nelfinavir, ritonavir, or delavirdine in combination with saquinavir-SGC and stavudine in treatment-experienced HIV-1-infected patients.The use of efavirenz as a part of late rescue antiretroviral treatment.Social support, medication compliance and HIV/AIDS.Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy.Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
P2860

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy.

Item
http://www.wikidata.org/entity/Q45745942
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Clinical and immunologic respo ...... active antiretroviral therapy.
@en
Clinical and immunologic respo ...... active antiretroviral therapy.
@nl
type
label
Clinical and immunologic respo ...... active antiretroviral therapy.
@en
Clinical and immunologic respo ...... active antiretroviral therapy.
@nl
prefLabel
Clinical and immunologic respo ...... active antiretroviral therapy.
@en
Clinical and immunologic respo ...... active antiretroviral therapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Clinical and immunologic respo ...... active antiretroviral therapy.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698